Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
The agency said the combination would hurt competition for cancer-detection tests while raising prices. Source link
The 'King Kong' of Weight-Loss Drugs Is Coming
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
Medicaid Eligibility Changes Set to Hit Hospitals, Insurers, States
Politics Health Policy Millions could lose coverage as their eligibility is reviewed, with financial effects rippling through the healthcare industry Source link
China's Consumers Extend Economic Rebound From Pandemic
A gauge of activity in China’s services sector reached its highest level in more than a decade in March, a sign that Chinese consumers are
Exodus From America's Big Cities Slowed Last Year as Pandemic Receded
New census figures show suburbs and smaller metro areas claimed the most growth in the U.S. from mid-2021 to mid-2022. Source link
Americans to Be Barred From Buying Ozempic in British Columbia
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. Source link
China's Economic Coercion Needs Congressional Response, Ambassador Says
Rahm Emanuel, the U.S. ambassador to Japan, calls for a global coalition of U.S. allies to help those countries targeted by Beijing. Source link
Regeneron, Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. Source link
